On ECHEMI
Home > Drugs > Hemochromatosis cardiomyopathy
Hemochromatosis cardiomyopathy
Hemochromatosis (HCH) is a chronic systemic disease of iron metabolism disorder, which is distributed worldwide. Since it was reported by Troussean in 1865, there have been more and more reports on this disease in the world. The disease is characterized by a hereditary iron metabolism disorder, with hemosiderin deposited in tissues, causing damage to multiple organs such as the liver, spleen, adrenal glands, pituitary glands, pancreas, heart, fibrosis, structural destruction and functional disorders.
  • Site of disease:

    heart
  • Infectious :

    Not contagious
  • Frequent population:

    More common in men
  • Related symptoms:

    Difficulty breathing palpitations dizziness fatigue shortness of breath after activity
  • Concurrent disease:

Related Drugs
Nifedipine extended-release tablets
Indication: Various types of hypertensive angina.
Manufacturer:

Hunan Warrant Pharmaceutical Co., Ltd.

Nifedipine extended-release tablets
Indication: Various types of hypertension and angina pectoris.
Manufacturer:

Hunan Warrant Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.